Condition: Mild Hypoxic Ischemic Encephalopathy of Newborn · Sponsor: University of Texas Southwestern Medical Center
To determine effectiveness of therapy to improve neurodevelopmental outcomes in infants with mild HIE. To determine the adverse effects of Therapeutic Hypothermia (TH) in mild HIE on the neonate and his/her family. Determine heterogeneity of the treatment effect across key subgroups obtained in the first 6 hours after birth prior to the decision to initiate therapy.
This description comes directly from the study's public registry record.
Lina Chalak, MD · 214-648-3903 · lina.chalak@utsouthwestern.edu
Pollieanna Sepulveda, MSN, RN · 214-648-3698 · pollieanna.sepulveda@utsouthwestern.edu
Always discuss trial participation with your own doctor first.
| University of Texas Southwestern Medical Center | Dallas, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04621279